MedPath

Aspirin

Generic Name
Aspirin
Brand Names
Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala
Drug Type
Small Molecule
Chemical Formula
C9H8O4
CAS Number
50-78-2
Unique Ingredient Identifier
R16CO5Y76E

Overview

Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) . Interestingly, the results of various studies have demonstrated that long-term use of acetylsalicylic acid may decrease the risk of various cancers, including colorectal, esophageal, breast, lung, prostate, liver and skin cancer . Aspirin is classified as a non-selective cyclooxygenase (COX) inhibitor and is available in many doses and forms, including chewable tablets, suppositories, extended release formulations, and others . Acetylsalicylic acid is a very common cause of accidental poisoning in young children. It should be kept out of reach from young children, toddlers, and infants .

Background

Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) . Interestingly, the results of various studies have demonstrated that long-term use of acetylsalicylic acid may decrease the risk of various cancers, including colorectal, esophageal, breast, lung, prostate, liver and skin cancer . Aspirin is classified as a non-selective cyclooxygenase (COX) inhibitor and is available in many doses and forms, including chewable tablets, suppositories, extended release formulations, and others . Acetylsalicylic acid is a very common cause of accidental poisoning in young children. It should be kept out of reach from young children, toddlers, and infants .

Indication

Pain, fever, and inflammation Acetylsalicylic acid (ASA), in the regular tablet form (immediate-release), is indicated to relieve pain, fever, and inflammation associated with many conditions, including the flu, the common cold, neck and back pain, dysmenorrhea, headache, tooth pain, sprains, fractures, myositis, neuralgia, synovitis, arthritis, bursitis, burns, and various injuries. It is also used for symptomatic pain relief after surgical and dental procedures . The extra strength formulation of acetylsalicylic acid is also indicated for the management migraine pain with photophobia (sensitivity to light) and phonophobia (sensitivity to sound). Other indications ASA is also indicated for various other purposes, due to its ability to inhibit platelet aggregation. These include: Reducing the risk of cardiovascular death in suspected cases of myocardial infarction (MI) . Reducing the risk of a first non-fatal myocardial infarction in patients, and for reducing the risk of morbidity and mortality in cases of unstable angina and in those who have had a prior myocardial infarction . For reducing the risk of transient ischemic attacks (TIA) and to prevent atherothrombotic cerebral infarction (in conjunction with other treatments) . For the prevention of thromboembolism after hip replacement surgery . For decreasing platelet to platelet adhesion following carotid endarterectomy, aiding in the prevention of transient ischemic attacks (TIA) . Used for patients undergoing hemodialysis with a silicone rubber arteriovenous cannula inserted to prevent thrombosis at the insertion site . Important note regarding use of the extended-release formulation In the setting of acute myocardial infarction, or before percutaneous interventions, the extended-release form of acetylsalicylic acid should not be used. Use immediate-release formulations in scenarios requiring rapid onset of action . The extended-release form is taken to decrease the incidence of mortality and myocardial infarction (MI) for individuals diagnosed with chronic coronary artery disease (CAD), including patients with previous myocardial infarction (MI) or unstable angina or with chronic stable angina. Additionally, the extended-release form is used to decrease the risk of death and recurrent episodes of stroke in patients with a history of stroke or TIA .

Associated Conditions

  • Acute Coronary Syndrome (ACS)
  • Anxiety
  • Atherothrombotic cerebral infarction
  • Cardiovascular Disease (CVD)
  • Cardiovascular Events
  • Cardiovascular Mortality
  • Colorectal Adenomas
  • Colorectal Cancer
  • Common Cold
  • Coronary artery reocclusion
  • Death
  • Dyspeptic signs and symptoms
  • Fever
  • Flu caused by Influenza
  • Headache
  • Heterozygous Familial Hypercholesterolemia (HeFH)
  • Inflammation
  • Juvenile Idiopathic Arthritis (JIA)
  • Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
  • Menstrual Pain
  • Migraine
  • Morbidity
  • Mucocutaneous Lymph Node Syndrome
  • Muscle Contraction
  • Myalgia
  • Myocardial Infarction
  • Myocardial Infarction (MI), first occurrence
  • Neuropathic Pain
  • Pain
  • Pain caused by Common Cold
  • Pain caused by Rheumatism
  • Pericarditis
  • Polycythemia Vera (PV)
  • Pre-Eclampsia
  • Rheumatism
  • Rheumatoid Arthritis
  • Rhino Sinusitis
  • Severe Pain
  • Spondyloarthropathies
  • Stroke
  • Systemic Lupus Erythematosus
  • Tension Headache
  • Thromboembolism
  • Thrombosis
  • Toothache
  • Transient Ischemic Attack
  • Vascular Death
  • Venous Thromboembolism
  • Acute Inflammation
  • Articular inflammation
  • Atherothrombotic events
  • Death caused by Myocardial Infarction
  • Fever or influenza-like illness
  • Moderate Pain
  • Recurrent Ischemic Stroke

FDA Approved Products

Oxycodone and Aspirin
Manufacturer:Epic Pharma, LLC
Route:ORAL
Strength:325 mg in 1 1
Approved: 2023/09/18
NDC:42806-061
Butalbital, aspirin, and caffeine
Manufacturer:Lannett Company, Inc.
Route:ORAL
Strength:325 mg in 1 1
Approved: 2024/01/30
NDC:0527-1552
Ascomp with Codeine
Manufacturer:Breckenridge Pharmaceutical, Inc.
Route:ORAL
Strength:325 mg in 1 1
Approved: 2023/09/30
NDC:51991-074
Butalbital, Aspirin, and Caffeine
Manufacturer:LGM Pharma Solutions, LLC
Route:ORAL
Strength:500 mg in 1 1
Approved: 2021/10/18
NDC:79739-7192
Aspirin and Extended-Release Dipyridamole
Manufacturer:Amneal Pharmaceuticals LLC
Route:ORAL
Strength:25 mg in 1 1
Approved: 2023/12/18
NDC:65162-596

Singapore Approved Products

ASPIRIN (E.C.) TABLETS 100 mg
Manufacturer:BEACONS PHARMACEUTICALS PTE. LTD.
Form:ENTERIC COATED TABLET
Strength:100 mg
Online:Yes
Approved: 1991/01/29
Approval:SIN05373P
BOKEY ENTERIC-MICROENCAPSULATED CAPSULES 100 mg
Manufacturer:YUNG SHIN PHARMACEUTICAL IND CO LTD, YSP Industries (M) Sdn Bhd
Form:CAPSULE
Strength:100.00 mg
Online:Yes
Approved: 1996/11/07
Approval:SIN08997P
GLYPRIN DISPERSIBLE TABLET
Manufacturer:DUOPHARMA MANUFACTURING (BANGI) SDN.BHD.
Form:TABLET
Strength:100 mg
Online:Yes
Approved: 2003/01/24
Approval:SIN12172P
CARDIPRIN 100 TABLET 100 mg
Manufacturer:RECKITT BENCKISER HEALTHCARE (UK) LTD
Form:TABLET
Strength:100 mg
Online:Yes
Approved: 1991/01/08
Approval:SIN05313P
BAYER ASPIRIN TABLET 500 mg
Manufacturer:PT Bayer Indonesia, Bayer S.A.
Form:TABLET
Strength:500 mg
Online:Yes
Approved: 1991/01/29
Approval:SIN05362P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath